-
1
-
-
0029066873
-
Neuronal nicotinic receptors: Function, modulation and structure
-
Albuquerque, E. X.; Pereira, E. F. R.; Castro, N. G.; Alkondon, M.: Neuronal nicotinic receptors: Function, modulation and structure. Sem. Neurosci. 7:91-101; 1995.
-
(1995)
Sem. Neurosci.
, vol.7
, pp. 91-101
-
-
Albuquerque, E.X.1
Pereira, E.F.R.2
Castro, N.G.3
Alkondon, M.4
-
3
-
-
0028934741
-
Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21
-
Arendash, G. W.; Sengstock, G. J.; Sanberg, P. R.; Kem, W. R.: Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 674:252-259; 1995.
-
(1995)
Brain Res.
, vol.674
, pp. 252-259
-
-
Arendash, G.W.1
Sengstock, G.J.2
Sanberg, P.R.3
Kem, W.R.4
-
4
-
-
0028343246
-
(S)-3-Methyl-5-(1-Methyl-2-Pyrrolidinyl) Isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization
-
Arneric, S. P.; Sullivan, J. P.; Briggs, C. A.; Donnelly-Roberts, D.; Anderson, D. J.; Raskiewicz, J. L.; Hughes, M. L.; Cadman, E. D.; Adams, P.; Garvey, D. S.; Wasicak, J.; Williams, M.: (S)-3-Methyl-5-(1-Methyl-2-Pyrrolidinyl) Isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J. Pharmacol. Exp. Ther. 270:310-318; 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.270
, pp. 310-318
-
-
Arneric, S.P.1
Sullivan, J.P.2
Briggs, C.A.3
Donnelly-Roberts, D.4
Anderson, D.J.5
Raskiewicz, J.L.6
Hughes, M.L.7
Cadman, E.D.8
Adams, P.9
Garvey, D.S.10
Wasicak, J.11
Williams, M.12
-
5
-
-
0029086251
-
Potential treatment of Alzheimer's Disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like and cytoprotective properties
-
Arneric, S. P.; Sullivan, J. P.; Decker, M. W.; Brioni, J. D.; Bannon, A. W.; Briggs, C. A.; Donnelly-Roberts, D.; Radek, R. J.; Marsh, K. C.; Kyncl, J.; Williams, M.; Buccafusco, J. J.: Potential treatment of Alzheimer's Disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like and cytoprotective properties. Alzheimer Disease and Associated Disorders 9 (Suppl. 2):50-61; 1995.
-
(1995)
Alzheimer Disease and Associated Disorders
, vol.9
, Issue.2 SUPPL.
, pp. 50-61
-
-
Arneric, S.P.1
Sullivan, J.P.2
Decker, M.W.3
Brioni, J.D.4
Bannon, A.W.5
Briggs, C.A.6
Donnelly-Roberts, D.7
Radek, R.J.8
Marsh, K.C.9
Kyncl, J.10
Williams, M.11
Buccafusco, J.J.12
-
6
-
-
0026343407
-
Nicotine and coronary heart disease
-
Benowitz, N. L.: Nicotine and coronary heart disease. Trends Cardiovasc. Med. 1:315-321; 1991.
-
(1991)
Trends Cardiovasc. Med.
, vol.1
, pp. 315-321
-
-
Benowitz, N.L.1
-
7
-
-
0018134270
-
The binding of agonists to brain muscarinic receptors
-
Birdsall, N. J. M.; Burgen, A. S. V.; Hulme, E. C.: The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 14:723-736; 1978.
-
(1978)
Mol. Pharmacol.
, vol.14
, pp. 723-736
-
-
Birdsall, N.J.M.1
Burgen, A.S.V.2
Hulme, E.C.3
-
8
-
-
0028979585
-
Human α7 nicotinic acetylcholine receptor responses to novel ligands
-
Briggs, C. A.; McKenna, D. G.; Piattoni-Kaplan, M.: Human α7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology 34:583-590; 1995.
-
(1995)
Neuropharmacology
, vol.34
, pp. 583-590
-
-
Briggs, C.A.1
McKenna, D.G.2
Piattoni-Kaplan, M.3
-
9
-
-
0029062212
-
ABT-418: Discriminative stimulus properties and ventral tegmental cell activity
-
Brioni, J. D.; Kim, D. J. B.; Brodie, M. S.; Decker, M. W.; Arneric, S. P.: ABT-418: Discriminative stimulus properties and ventral tegmental cell activity. Psychopharmacology 119:368-375; 1995.
-
(1995)
Psychopharmacology
, vol.119
, pp. 368-375
-
-
Brioni, J.D.1
Kim, D.J.B.2
Brodie, M.S.3
Decker, M.W.4
Arneric, S.P.5
-
10
-
-
0028205757
-
Clozapine attenuates the discriminative stimulus properties of (-)-nicotine
-
Brioni, J. D.; Kim, D. J. B.; O'Neill, A. B.; Williams, J. E. G.; Decker, M. W.: Clozapine attenuates the discriminative stimulus properties of (-)-nicotine. Brain Res. 643:1-9; 1994.
-
(1994)
Brain Res.
, vol.643
, pp. 1-9
-
-
Brioni, J.D.1
Kim, D.J.B.2
O'Neill, A.B.3
Williams, J.E.G.4
Decker, M.W.5
-
11
-
-
0027232237
-
Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test
-
Brioni, J. D.; O'Neill, A. B.; Kim, D. J. B.; Decker, M. W.: Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238:1-8; 1993.
-
(1993)
Eur. J. Pharmacol.
, vol.238
, pp. 1-8
-
-
Brioni, J.D.1
O'Neill, A.B.2
Kim, D.J.B.3
Decker, M.W.4
-
12
-
-
0342758856
-
ABT-418: The anxiolytic and discriminative stimulus properties in rodents
-
Brioni, J. D.; O'Neill, A. B.; Kim, D. J. B.; Decker, M. W.; Arneric, S. P.: ABT-418: The anxiolytic and discriminative stimulus properties in rodents. Soc. Neurosci. Abstr. 20:174; 1994.
-
(1994)
Soc. Neurosci. Abstr.
, vol.20
, pp. 174
-
-
Brioni, J.D.1
O'Neill, A.B.2
Kim, D.J.B.3
Decker, M.W.4
Arneric, S.P.5
-
13
-
-
0025780198
-
Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys
-
Buccafusco, J. J.; Jackson, W. J.: Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol. Aging 12:233-238; 1991.
-
(1991)
Neurobiol. Aging
, vol.12
, pp. 233-238
-
-
Buccafusco, J.J.1
Jackson, W.J.2
-
14
-
-
0028181720
-
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)
-
Bymaster, F. P.; Wong, D. T.; Mitch, C. H.; Ward, J. S.; Calligaro, D. O.; Schoepp, D. D.; Shannon, H. E.; Sheardown, M. J.; Olesen, P. H.; Suzdak, P. D.: Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232). J. Pharmacol. Exp. Ther. 269:282-289; 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.269
, pp. 282-289
-
-
Bymaster, F.P.1
Wong, D.T.2
Mitch, C.H.3
Ward, J.S.4
Calligaro, D.O.5
Schoepp, D.D.6
Shannon, H.E.7
Sheardown, M.J.8
Olesen, P.H.9
Suzdak, P.D.10
-
15
-
-
0027431495
-
Effects of mutations of Torpedo acetylcholine receptor α1 subunit residues 184-200 on α-bungarotoxin binding in a recombinant fusion protein
-
Chaturvedi, V.; Donnelly-Roberts, D. L.; Lentz, T. L.: Effects of mutations of Torpedo acetylcholine receptor α1 subunit residues 184-200 on α-bungarotoxin binding in a recombinant fusion protein. Biochem. 32:9570-9576; 1993.
-
(1993)
Biochem.
, vol.32
, pp. 9570-9576
-
-
Chaturvedi, V.1
Donnelly-Roberts, D.L.2
Lentz, T.L.3
-
17
-
-
0026758504
-
The fall and rise of neuronal α-bungarotoxin binding proteins
-
Clarke, P. B. S.: The fall and rise of neuronal α-bungarotoxin binding proteins. Trends Pharmacol. Sci. 13:407-413; 1992.
-
(1992)
Trends Pharmacol. Sci.
, vol.13
, pp. 407-413
-
-
Clarke, P.B.S.1
-
18
-
-
0020686674
-
Alzheimer's Disease: A disorder of cortical cholinergic innervation
-
Coyle, J. T.; Price, D. L.; DeLong, M. R.: Alzheimer's Disease: A disorder of cortical cholinergic innervation. Science 219:1189-1190; 1983.
-
(1983)
Science
, vol.219
, pp. 1189-1190
-
-
Coyle, J.T.1
Price, D.L.2
DeLong, M.R.3
-
19
-
-
0028198828
-
Tacrine: First drug approved for Alzheimer's Disease
-
Crismon, M. L.: Tacrine: First drug approved for Alzheimer's Disease. Ann. Pharmacother. 28:744-751; 1994.
-
(1994)
Ann. Pharmacother.
, vol.28
, pp. 744-751
-
-
Crismon, M.L.1
-
20
-
-
0029059903
-
Muscarinic M1 receptor agonists: Potential in the treatment of Alzheimer's Disease
-
Cutler, N. R.; Sramek, J. J.: Muscarinic M1 receptor agonists: Potential in the treatment of Alzheimer's Disease. CNS Drugs 3:467-481; 1995.
-
(1995)
CNS Drugs
, vol.3
, pp. 467-481
-
-
Cutler, N.R.1
Sramek, J.J.2
-
23
-
-
0026503635
-
Effects of nicotine on spatial memory deficits in rats with septal lesions
-
Decker, M. W.; Majchrzak, M. J.; Anderson, D. J.: Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res. 572:281-285; 1992.
-
(1992)
Brain Res.
, vol.572
, pp. 281-285
-
-
Decker, M.W.1
Majchrzak, M.J.2
Anderson, D.J.3
-
24
-
-
0025968656
-
Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors
-
Deneris, E. S.; Connolly, J.; Rogers, S. W.; Duvoisin, R.: Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12:34-40; 1991.
-
(1991)
Trends Pharmacol. Sci.
, vol.12
, pp. 34-40
-
-
Deneris, E.S.1
Connolly, J.2
Rogers, S.W.3
Duvoisin, R.4
-
25
-
-
0027363742
-
Role of forebrain cholinergic systems in learning and memory: Relevance to the cognitive deficits of aging and Alzheimer's dementia
-
Dunnett, S. B.; Fibiger, H. C.: Role of forebrain cholinergic systems in learning and memory: Relevance to the cognitive deficits of aging and Alzheimer's dementia. Prog. Brain Res. 98:413-420; 1993.
-
(1993)
Prog. Brain Res.
, vol.98
, pp. 413-420
-
-
Dunnett, S.B.1
Fibiger, H.C.2
-
26
-
-
0016697198
-
Properties of γ-aminobutyric acid receptor binding in rat brain synaptic membrane fractions
-
Enna, S. J.; Snyder, S. H.: Properties of γ-aminobutyric acid receptor binding in rat brain synaptic membrane fractions. Brain Res. 100:81-87; 1975.
-
(1975)
Brain Res.
, vol.100
, pp. 81-87
-
-
Enna, S.J.1
Snyder, S.H.2
-
27
-
-
0026593533
-
A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment
-
Flores, C. M.; Rogers, S. W.; Pabreza, L. A.; Wolfe, B. B.; Kellar, K. J.: A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41:31-37; 1992.
-
(1992)
Mol. Pharmacol.
, vol.41
, pp. 31-37
-
-
Flores, C.M.1
Rogers, S.W.2
Pabreza, L.A.3
Wolfe, B.B.4
Kellar, K.J.5
-
28
-
-
0028984455
-
Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor
-
Gopalakrishnan, M.; Buisson, B.; Touma, E.; Giordano, T.; Campbell, J. E.; Hu, I. C.; Donnelly-Roberts, D.; Arneric, S. P.; Bertrand, D.; Sullivan, J. P.: Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur. J. Pharmacol. Mol. Pharmacol. 290:237-246; 1995.
-
(1995)
Eur. J. Pharmacol. Mol. Pharmacol.
, vol.290
, pp. 237-246
-
-
Gopalakrishnan, M.1
Buisson, B.2
Touma, E.3
Giordano, T.4
Campbell, J.E.5
Hu, I.C.6
Donnelly-Roberts, D.7
Arneric, S.P.8
Bertrand, D.9
Sullivan, J.P.10
-
29
-
-
0029936826
-
Stable expression, pharmacologic properties and regulation of human nicotinic acetylcholine α4β2 receptor
-
Gopalakrishnan, M.; Monteggia, L. M.; Anderson, D. J.; Arneric, S. P.; Sullivan, J. P.: Stable expression, pharmacologic properties and regulation of human nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Exp. Ther. 276:289-297; 1995.
-
(1995)
J. Pharmacol. Exp. Ther.
, vol.276
, pp. 289-297
-
-
Gopalakrishnan, M.1
Monteggia, L.M.2
Anderson, D.J.3
Arneric, S.P.4
Sullivan, J.P.5
-
30
-
-
0028874179
-
Therapeutic approaches for memory impairments
-
Hock, F. J.: Therapeutic approaches for memory impairments. Behav. Brain Res. 66:143-150; 1995.
-
(1995)
Behav. Brain Res.
, vol.66
, pp. 143-150
-
-
Hock, F.J.1
-
31
-
-
0028173895
-
A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus
-
Hunter, B. E.; de Fiebre, C. M.; Papke, R. L.; Kem, W. R.; Meyer, E. M.: A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:130-134; 1994.
-
(1994)
Neurosci. Lett.
, vol.168
, pp. 130-134
-
-
Hunter, B.E.1
De Fiebre, C.M.2
Papke, R.L.3
Kem, W.R.4
Meyer, E.M.5
-
32
-
-
0026356071
-
Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides
-
Listerud, M.; Brussaard, A. B.; Devay, P.; Colman, D. R.; Role, L. W.: Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. Science 254:1518-1521; 1991.
-
(1991)
Science
, vol.254
, pp. 1518-1521
-
-
Listerud, M.1
Brussaard, A.B.2
Devay, P.3
Colman, D.R.4
Role, L.W.5
-
33
-
-
0027375195
-
Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line
-
Lukas, R. J.: Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J. Pharmacol. Exp. Ther. 265:294-302; 1993.
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.265
, pp. 294-302
-
-
Lukas, R.J.1
-
34
-
-
0023029997
-
Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin
-
Marks, M. J.; Stitzel, J. A.; Romm, E.; Wehner, J. M.; Collins, A. C.: Nicotinic binding sites in rat and mouse brain: Comparison of acetylcholine, nicotine and α-bungarotoxin. Mol. Pharmacol. 30:427-436; 1986.
-
(1986)
Mol. Pharmacol.
, vol.30
, pp. 427-436
-
-
Marks, M.J.1
Stitzel, J.A.2
Romm, E.3
Wehner, J.M.4
Collins, A.C.5
-
35
-
-
0028194977
-
Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons
-
Martin, E. J.; Panickar, K. S.; King, M. A.; Deyrup, M.; Hunter, B. E.; Wang, G. H.; Meyer, E. M.: Cytoprotective actions of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev. Res. 31:135-141; 1994.
-
(1994)
Drug Dev. Res.
, vol.31
, pp. 135-141
-
-
Martin, E.J.1
Panickar, K.S.2
King, M.A.3
Deyrup, M.4
Hunter, B.E.5
Wang, G.H.6
Meyer, E.M.7
-
36
-
-
0028965629
-
Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
-
McGehee, D. S.; Role, L. W.: Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:521-546; 1995.
-
(1995)
Annu. Rev. Physiol.
, vol.57
, pp. 521-546
-
-
McGehee, D.S.1
Role, L.W.2
-
37
-
-
0028202910
-
Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors
-
Meyer, E. M.; de Fiebre, C. M.; Hunter, B. E.; Simpkins, C. E.; Frauworth, N.; De Fiebre, N. E. C.: Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31:127-134; 1994.
-
(1994)
Drug Dev. Res.
, vol.31
, pp. 127-134
-
-
Meyer, E.M.1
De Fiebre, C.M.2
Hunter, B.E.3
Simpkins, C.E.4
Frauworth, N.5
De Fiebre, N.E.C.6
-
39
-
-
0027290947
-
The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversity
-
Papke, R. L.: The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversity. Prog. Neurobiol. 41:509-531; 1993.
-
(1993)
Prog. Neurobiol.
, vol.41
, pp. 509-531
-
-
Papke, R.L.1
-
40
-
-
0022374863
-
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
-
Pellow, S.; Chopin, P.; File, S. E.; Briley, M.: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14:149-167; 1985.
-
(1985)
J. Neurosci. Meth.
, vol.14
, pp. 149-167
-
-
Pellow, S.1
Chopin, P.2
File, S.E.3
Briley, M.4
-
41
-
-
0028226489
-
Expression of neuronal nicotinic acetylcholine receptor subunit genes in the rat autonomic nervous system
-
Rust, G.; Burgunder, J. -M.; Lauterburg, T. E.; Cachelin, A. B.: Expression of neuronal nicotinic acetylcholine receptor subunit genes in the rat autonomic nervous system. Eur. J. Neurosci. 6:478-485; 1994.
-
(1994)
Eur. J. Neurosci.
, vol.6
, pp. 478-485
-
-
Rust, G.1
Burgunder, J.M.2
Lauterburg, T.E.3
Cachelin, A.B.4
-
42
-
-
0024385514
-
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type
-
Sahakian, B.; Jones, G.; Levy, R.; Gray, J.; Warburton, D.: The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry 154:797-800; 1989.
-
(1989)
Br. J. Psychiatry
, vol.154
, pp. 797-800
-
-
Sahakian, B.1
Jones, G.2
Levy, R.3
Gray, J.4
Warburton, D.5
-
43
-
-
0027398069
-
The diversity of neuronal nicotinic acetylcholine receptors
-
Sargent, P. B.: The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:403-443; 1993.
-
(1993)
Annu. Rev. Neurosci.
, vol.16
, pp. 403-443
-
-
Sargent, P.B.1
-
44
-
-
0028344181
-
Xanomeline: A novel muscarinic receptor agonist with functional selectivity for M1 receptors
-
Shannon, H. E.; Bymaster, F. P.; Calligaro, D. O.; Greenwood, B.; Mitch, C. H.; Sawyer, B. D.; Ward, J. S.; Wong, D. T.; Olesen, P. H.; Sheardown, M. J.: Xanomeline: A novel muscarinic receptor agonist with functional selectivity for M1 receptors. J. Pharmacol. Exp. Ther. 269:271-281; 1994.
-
(1994)
J. Pharmacol. Exp. Ther.
, vol.269
, pp. 271-281
-
-
Shannon, H.E.1
Bymaster, F.P.2
Calligaro, D.O.3
Greenwood, B.4
Mitch, C.H.5
Sawyer, B.D.6
Ward, J.S.7
Wong, D.T.8
Olesen, P.H.9
Sheardown, M.J.10
-
45
-
-
0000696432
-
Parallel processing strategies in th eapplication of microcomputers to the behavioral laboratory
-
Spencer, D. G.; Emmett-Oglesby, M. W.:Parallel processing strategies in th eapplication of microcomputers to the behavioral laboratory. Behav. Res. Meth. Instrument. 17:294-300; 1985.
-
(1985)
Behav. Res. Meth. Instrument.
, vol.17
, pp. 294-300
-
-
Spencer, D.G.1
Emmett-Oglesby, M.W.2
-
46
-
-
0028985264
-
Nicotine psychopharmacology: Addiction, cognition and neuroadaptation
-
Stolerman, I. P.; Mirza, N. R.; Shoaib, M.: Nicotine psychopharmacology: Addiction, cognition and neuroadaptation. Med. Res. Rev. 15:47-72; 1995.
-
(1995)
Med. Res. Rev.
, vol.15
, pp. 47-72
-
-
Stolerman, I.P.1
Mirza, N.R.2
Shoaib, M.3
-
47
-
-
0027518923
-
Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium
-
Séguéla, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J. A.; Patrick, J. W.: Molecular cloning, functional properties, and distribution of rat brain α7: A nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:596-604; 1993.
-
(1993)
J. Neurosci.
, vol.13
, pp. 596-604
-
-
Séguéla, P.1
Wadiche, J.2
Dineley-Miller, K.3
Dani, J.A.4
Patrick, J.W.5
-
48
-
-
0027291370
-
Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys
-
Terry, A. V., Jr.; Buccafusco, J. J.; Jackson, W. J.: Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol. Biochem. Behav. 45:925-929; 1993.
-
(1993)
Pharmacol. Biochem. Behav.
, vol.45
, pp. 925-929
-
-
Terry A.V., Jr.1
Buccafusco, J.J.2
Jackson, W.J.3
-
49
-
-
0019410162
-
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
-
Whitehouse, P. J.; Price, D. L.; Clark, A. W.; Coyle, J. T.; DeLong, M. R.: Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:122-126; 1981.
-
(1981)
Ann. Neurol.
, vol.10
, pp. 122-126
-
-
Whitehouse, P.J.1
Price, D.L.2
Clark, A.W.3
Coyle, J.T.4
DeLong, M.R.5
-
50
-
-
0028199608
-
A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain
-
Woodruff-Pak, D. S.; Li, Y.-T.; Kem, W. R.: A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res. 645:309-317; 1994.
-
(1994)
Brain Res.
, vol.645
, pp. 309-317
-
-
Woodruff-Pak, D.S.1
Li, Y.-T.2
Kem, W.R.3
-
51
-
-
0002677769
-
Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modelling
-
Zoltewicz, J. A.; Prokai-Tatrai, K.; Bloom, L. B.; Kem, W. R.: Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modelling. Heterocycles 35:171-179; 1993.
-
(1993)
Heterocycles
, vol.35
, pp. 171-179
-
-
Zoltewicz, J.A.1
Prokai-Tatrai, K.2
Bloom, L.B.3
Kem, W.R.4
|